Telix Pharmaceuticals Financial Overview
Telix Pharmaceuticals's market cap is currently $2.82B. The company's EPS TTM is $0.01; its P/E ratio is 245.78; Telix Pharmaceuticals is scheduled to report earnings on August 20, 2025, and the estimated EPS forecast is $0.05. See an overview of income statement, balance sheet, and cash flow financials.
